FMP
Tyra Biosciences, Inc.
TYRA
NASDAQ
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
16.1 USD
0.6 (3.73%)
About
ceo
Dr. Todd Harris Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.tyra.bio
exchange
NASDAQ
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is...
CIK
0001863127
ISIN
US90240B1061
CUSIP
90240B106
Address
2656 State Street
Phone
619 728 4760
Country
US
Employee
49
IPO Date
Sep 15, 2021
Summary
CIK
0001863127
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
90240B106
ISIN
US90240B1061
Country
US
Price
16.1
Beta
1.12
Volume Avg.
141.54k
Market Cap
845.63M
Shares
-
52-Week
10.38-20.67
DCF
1.21
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-9.94
P/B
-
Website
https://www.tyra.bio
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TYRA News
It looks like there's no news available.
